missing translation for 'onlineSavingsMsg'
Learn More

PF-04691502, MedChemExpress

Product Code. 16482457
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16482457

Brand: Medchem Express HY15177

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress PF-04691502 is a potent and selective inhibitor of PI3K and mTOR. PF-04691502 binds to human PI3Kα, β, δ, γ and mTOR with Kis of 1.8, 2.1, 1.6, 1.9 and 16 nM, respectively.

PF-04691502 is a potent and selective inhibitor of PI3K and mTOR. PF-04691502 binds to human PI3Kα, β, δ, γ and mTOR with Kis of 1.8, 2.1, 1.6, 1.9 and 16 nM, respectively.

Specifications

Chemical Name or Material PF-04691502
Physical Form Solid
CAS 1013101-36-4
Color Gray
Quantity 50 mg
Purity Grade Notes Research
Molecular Formula C22H27N5O4
For Use With (Application) Cancer-Kinase/protease
Solubility Information DMSO : 50 mg/mL (117.51 mM; Need ultrasonic)
SMILES OCCO[C@@H]1CC[C@@H](N2C(N=C(N)N=C3C)=C3C=C(C4=CC=C(OC)N=C4)C2=O)CC1
Molecular Weight (g/mol) 425.48
Formula Weight 425.48
Percent Purity 98.89%
Grade Research
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.